Clinical Trial Update: Growth Hormone Treatment in Men With High Risk of Developing Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 trial of growth hormone treatment in men at high risk of developing type 2 diabetes mellitus has completed, evaluating effects in individuals with abd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Göteborg University | Conditions: Abdominal Obesity, Metabolic Syndrome | Phase 3 | Status: COMPLETED